13th May 2014 13:11
LONDON (Alliance News) - <strong>AstraZeneca</strong> Tuesday again rejected Pfizer's "opportunistic" GBP63 million takeover approach, as UK politicians grilled executives of both companies about the potential deal and what it will mean for the UK's pharmaceutical industry.<br /><br />Cruciall Read More